Biotech | March 22, 2022
Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform from target identification through patient selection. It will receive an upfront cash payment of US $ 100 million with the potential of US $ 5.2 billion in total milestones plus tiered royalties
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
The company will provide the technical and financial resources to support the study
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
Subscribe To Our Newsletter & Stay Updated
